Apollo Hospitals Gains 2.52%: 4 Key Factors Driving This Week’s Momentum

2 hours ago
share
Share Via
Apollo Hospitals Enterprise Ltd. recorded a 2.52% gain over the week ending 27 March 2026, closing at Rs.7,548.40, outperforming the Sensex which declined 1.46% during the same period. The stock experienced notable volatility, with a sharp decline on 23 March followed by two consecutive days of strong recovery supported by rising open interest in derivatives. This review analyses the key events shaping the stock’s performance and the broader market context.

Key Events This Week

23 Mar: Intraday low amid price pressure at Rs.7,100

24 Mar: Intraday high of Rs.7,388.05 with 3.1% surge and sharp open interest rise

25 Mar: Further open interest surge and intraday high of Rs.7,612.50

27 Mar: Week closes at Rs.7,548.40, down 0.44% on the day

Week Open
Rs.7,363.20
Week Close
Rs.7,548.40
+2.52%
Week High
Rs.7,612.50
vs Sensex
+3.98%

23 March 2026: Intraday Low Amid Market Pressure

On 23 March, Apollo Hospitals faced significant selling pressure, with its stock price falling 2.99% to close at Rs.7,143.30. The stock touched an intraday low of Rs.7,100, reflecting a 3.57% drop from previous levels. This decline was in line with the broader market, as the Sensex fell 3.13% to 32,377.87 amid sectoral weakness in hospital and healthcare services, which declined 3.26%. The stock traded below all key moving averages, signalling short-term bearish momentum. The broader market environment was fragile, with the Sensex nearing its 52-week low, contributing to cautious investor sentiment.

24 March 2026: Strong Rebound and Surge in Open Interest

Apollo Hospitals rebounded sharply on 24 March, gaining 3.76% to close at Rs.7,411.90, outperforming the Sensex’s 1.95% gain. The stock reached an intraday high of Rs.7,388.05, buoyed by strong buying interest and a gap-up opening of 2.49%. Technical indicators showed the stock trading above its 50-day and 100-day moving averages, suggesting medium-term strength despite short-term resistance. Notably, the derivatives market saw a 10.5% surge in open interest, rising from 38,556 to 42,613 contracts, accompanied by a high volume of 73,168 contracts traded. This increase in open interest alongside price gains indicates fresh long positions and bullish sentiment among traders. The stock’s futures and options turnover reflected robust liquidity and active hedging strategies, reinforcing its leadership within the hospital sector.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

25 March 2026: Continued Momentum and Record Open Interest

The positive momentum extended into 25 March, with Apollo Hospitals gaining 2.29% to close at Rs.7,581.50. The stock touched an intraday high of Rs.7,612.50, marking a 2.69% rise on the day. This performance was broadly in line with the hospital sector’s 2.38% advance and marginally outpaced the Sensex’s 1.97% gain. Open interest in derivatives surged by 22.16%, from 36,979 to 45,175 contracts, signalling strong market participation and directional bets. The futures segment alone accounted for a notional value of approximately ₹1,28,133 lakhs, while options contributed ₹36,942.6 crores, reflecting active hedging and speculative activity. The stock traded above its 5-day, 50-day, 100-day, and 200-day moving averages, indicating sustained medium- to long-term strength. Delivery volumes rose sharply, suggesting growing investor conviction and accumulation.

27 March 2026: Week Closes with Minor Retreat

On the final trading day of the week, Apollo Hospitals closed slightly lower by 0.44% at Rs.7,548.40, on heavy volume of 58,091 shares. The Sensex also declined 2.11% to 32,935.19, reflecting broader market weakness. Despite the minor retreat, the stock ended the week with a solid 2.52% gain from the previous Friday’s close of Rs.7,363.20, outperforming the Sensex’s 1.46% loss. The stock’s technical positioning remains constructive, supported by strong derivatives activity and sectoral tailwinds.

Apollo Hospitals Enterprise Ltd. or something better? Our SwitchER feature analyzes this large-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Daily Price Performance vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-03-23 Rs.7,143.30 -2.99% 32,377.87 -3.13%
2026-03-24 Rs.7,411.90 +3.76% 33,009.57 +1.95%
2026-03-25 Rs.7,581.50 +2.29% 33,645.89 +1.93%
2026-03-27 Rs.7,548.40 -0.44% 32,935.19 -2.11%

Key Takeaways

Positive Signals: Apollo Hospitals demonstrated resilience by outperforming the Sensex with a 2.52% weekly gain amid a broadly weak market. The sharp rebounds on 24 and 25 March were supported by strong derivatives market activity, including a 22.16% surge in open interest, signalling fresh long positions and bullish sentiment. The stock’s technical profile improved as it traded above multiple moving averages, indicating medium- to long-term strength. Rising delivery volumes suggest growing investor conviction and accumulation.

Cautionary Notes: The initial sharp decline on 23 March and the stock’s trading below some short-term moving averages highlight ongoing volatility and near-term resistance. The Mojo Score remains at 52.0 with a Hold rating, reflecting a balanced outlook amid sectoral and market uncertainties. The large notional values in options imply active hedging, which could lead to increased volatility around key strike prices. Investors should monitor technical signals and derivatives activity closely for signs of trend shifts.

Conclusion

Apollo Hospitals Enterprise Ltd. navigated a volatile week with a net positive outcome, gaining 2.52% while the Sensex declined 1.46%. The stock’s performance was shaped by a sharp initial sell-off followed by strong rebounds supported by significant open interest surges in derivatives, reflecting renewed market interest and positioning. Technical indicators suggest medium- to long-term strength, although short-term resistance and cautious analyst ratings advise vigilance. Overall, Apollo Hospitals remains a key player in the hospital sector, demonstrating relative resilience amid broader market fluctuations.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News